Pathway framework 8 of 8
How to get a medicine to patients by following it through approval and pricing
Do you want to learn how public bodies decide which medicines and prevention measures reach people, and at what price? You follow a new medicine through approval and pricing, then learn how to measure whether the gains from health policy reach the people who need them most.
4 steps
This framework organises the concepts covered at each step of the pathway on the Knowledge Map.
Concepts from other branches of the Knowledge Tree that this pathway builds on.
Step 1
How a new medicine gains approval and how its safety is watched once patients use it, including faster routes for serious conditions.
8 concepts
Why start here
The pathway starts with drug development and regulation, because a medicine must be approved before anyone can set its price or judge its value.
Step 2
How the price of a medicine is set and agreed with payers, and the deals that let patients get it when the cost is high or paid over time.
5 concepts
Why this comes next
Once a medicine is approved, its price and the terms of payment decide whether patients can get it, so pricing follows regulation.
Step 3
How governments use measures such as vaccination programmes and limits on alcohol to prevent illness across a whole population.
2 concepts
Why this comes next
Not all health policy concerns single medicines, so the pathway widens to measures that act on a whole population before people fall ill.
Step 4
How differences in health and in access to care are measured, which of them count as unfair, and how an evaluation can show who gains and who loses.
26 concepts
Why this comes next
With medicines and prevention policy in place, the last step asks whether their gains are shared fairly, which needs its own measures and methods.
Branches that take these methods further.